Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Cipla Ltd

NSE: CIPLA · BSE: 500087 · Pharmaceuticals & Biotechnology · 44 announcements

Share price
₹1,340.20
Market cap
₹1,08,271 Cr
Revenue (annual)
₹28,163 Cr
Net profit (annual)
₹3,879 Cr
P/E (TTM)
32.1×Sector 47.4×
Promoter holding
29.21%+0.00% QoQ
FII holding
20.20%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:56 IST BSE
Management Change

Cipla Management Change

Cipla Ltd announced that Mr. Venkata Sai Mungara has transitioned to a subsidiary role, ceasing to be a Senior Management Personnel effective October 1, 2026.

13:14 IST NSE
Management Change

Cipla Management Change

Cipla has appointed Mr. Dinesh Jain as Global CFO. Mr. Ashish Aduka transitions to an internal business leadership role.

22:11 IST NSE
Management Change

Cipla Management Change

Cipla Limited appointed B S R & Co. LLP as Statutory Auditor for a five-year term. This follows the tenure completion of Walker Chandiok & Co. LLP.

Execution
60 months
20:40 IST NSE
Management Change

Cipla Management Change

Cipla appointed Sushrut Kulkarni as President and Global Chief of Integrated Product Development. The firm also appointed Joshi Apte & Associates as new Cost Auditors.

Execution
12 months (Cost Auditor term)